- Home
- CMMB vs JBDI Comparison
CMMB vs JBDI Comparison
Compare CMMB & JBDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- JBDI
- Stock Information
- Founded
- CMMB 2004
- JBDI 1983
- Country
- CMMB Israel
- JBDI Singapore
- Employees
- CMMB N/A
- JBDI N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- JBDI
- Sector
- CMMB Health Care
- JBDI
- Exchange
- CMMB Nasdaq
- JBDI Nasdaq
- Market Cap
- CMMB 22.0M
- JBDI 19.0M
- IPO Year
- CMMB N/A
- JBDI 2024
- Fundamental
- Price
- CMMB $1.13
- JBDI $1.01
- Analyst Decision
- CMMB Strong Buy
- JBDI
- Analyst Count
- CMMB 2
- JBDI 0
- Target Price
- CMMB $8.50
- JBDI N/A
- AVG Volume (30 Days)
- CMMB 187.2K
- JBDI 133.3K
- Earning Date
- CMMB 08-20-2025
- JBDI 02-15-2025
- Dividend Yield
- CMMB N/A
- JBDI N/A
- EPS Growth
- CMMB N/A
- JBDI N/A
- EPS
- CMMB N/A
- JBDI N/A
- Revenue
- CMMB N/A
- JBDI $9,017,000.00
- Revenue This Year
- CMMB N/A
- JBDI N/A
- Revenue Next Year
- CMMB N/A
- JBDI N/A
- P/E Ratio
- CMMB N/A
- JBDI N/A
- Revenue Growth
- CMMB N/A
- JBDI N/A
- 52 Week Low
- CMMB $0.87
- JBDI $0.49
- 52 Week High
- CMMB $2.55
- JBDI $39.41
- Technical
- Relative Strength Index (RSI)
- CMMB 42.55
- JBDI N/A
- Support Level
- CMMB $1.17
- JBDI N/A
- Resistance Level
- CMMB $1.23
- JBDI N/A
- Average True Range (ATR)
- CMMB 0.05
- JBDI 0.00
- MACD
- CMMB 0.00
- JBDI 0.00
- Stochastic Oscillator
- CMMB 34.11
- JBDI 0.00
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About JBDI JBDI Holdings Limited Ordinary Shares
JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.